Reading Osteoporosis DXA Results Alongside Fracture History
Understand who T-score categories apply to, distinguish U.S. FRAX thresholds from universal rules, and organize skeletal-site, fracture and medicine records for a clinical discussion.
Publication & corrections: infostoa · Editorial standards
Individual author and specialist reviewer information is not provided for this article.
1. What a DXA bone density test measures
Dual-energy X-ray absorptiometry (DXA, also called DEXA) is a common test that measures bone mineral density, usually at the spine and hip. It is used to diagnose osteoporosis, estimate fracture risk, and monitor treatment. A DXA result is one part of fracture assessment; it does not directly measure every aspect of bone microarchitecture or a person’s overall risk. It should be interpreted with fracture history, medications, fall risk, and relevant health conditions.
2. Who the T-score categories apply to
The Bone Health and Osteoporosis Foundation (BHOF) uses T-scores for diagnostic classification in postmenopausal women and men age 50 years or older. In these groups, a T-score of -1.0 or above is normal, between -1.0 and -2.5 is low bone mass (osteopenia), and -2.5 or below is in the osteoporosis range. This classification should not simply be applied to premenopausal women or men younger than 50; age-appropriate Z-scores and clinical context are used instead. A threshold alone does not determine every patient’s diagnosis.
3. Fracture history and FRAX add context
A hip or vertebral fragility fracture may be important to diagnosis and treatment even when the DXA T-score is above -2.5. BHOF advises considering fracture history and other clinical risk factors. FRAX estimates 10-year fracture probability from age, sex, bone density, and clinical factors; it is not an automatic diagnostic test. For U.S. postmenopausal women and men age 50 or older with low bone mass, BHOF describes treatment intervention thresholds of a 10-year probability of at least 20% for major osteoporotic fracture or at least 3% for hip fracture. These are U.S. guidance thresholds for that population and should not be presented as universal cutoffs.
4. Imaging limitations and institutional guidance
Degenerative changes in the spine can complicate interpretation of spinal DXA. BHOF notes that quantitative computed tomography may be useful when degenerative spinal disease is present, and DXA alone cannot capture every factor relevant to fracture risk. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) likewise describes bone density testing alongside risk factors and clinical evaluation. A clinician should interpret results in light of the measured site, image quality, age, prior fractures, and other risks. This summary reflects the 2022 BHOF clinician consensus guide and NIAMS patient information; it is not attributed to an individual expert.
5. A record connecting results and fracture history
Bring: “test date / age and menopausal status / skeletal site / BMD and T- or Z-score / prior fracture site and circumstances / medicine names and duration / recent falls / previous testing facility.” ISCD’s official positions distinguish diagnostic classification from fracture-risk assessment.
In a fictional postmenopausal woman with a femoral-neck T-score of −2.0 and a prior low-trauma vertebral fracture, do not write “no fracture risk” merely because the score exceeds −2.5. Write “low-bone-mass score; fracture history needs separate assessment” for discussion with a clinician. This is not a treatment prescription. A slightly higher later score does not by itself prove improvement: site, equipment and measurement error matter. Ask the testing facility whether results are comparable.